Physician profile
Daniel E Simpson
NPI 1073539078
$3,426.98
in general payments reported to CMS, 2019-2025
22 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $292 · 2021: $315 · 2022: $312 · 2023: $870 · 2024: $748 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,882.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $977.05 | 2020-2025 | Xience Skypoint, Ultreon, Xience Sierra |
| Abiomed | $397.57 | 2022-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $351.10 | 2020-2024 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $338.61 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $335.60 | 2019-2024 | |
| Edwards Lifesciences Corporation | $150.40 | 2021-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Pfizer INC. | $141.22 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $133.33 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $90.97 | 2021-2024 | Watchman Flx, Eluvia, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $85.11 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.78 | 2019-2021 | |
| Cardiovascular Systems INC. | $64.17 | 2019-2023 | Diamondback Coronary |
| Inari Medical, INC. | $52.79 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $45.44 | 2022 | |
| Amgen INC. | $36.17 | 2019-2024 | Repatha |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $30.17 | 2019 | |
| Lemaitre Vascular, INC. | $29.12 | 2019 | |
| Philips North America LLC | $26.65 | 2019-2023 | |
| Amarin Pharma, INC. | $24.97 | 2019 | |
| Ekos Corporation | $21.83 | 2019 | |
| Cardiva Medical, INC. | $15.58 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Gilead Sciences, INC. | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.